“…M2 macrophages are also a source of inhibitory cytokines such as IL-10 and TGF-β, which help to resolve inflammation and have been shown to protect from atherosclerosis (57,58). Moreover, of particular relevance to the present report, myeloid cells treated in vitro with M2-polarizing factors (e.g., IL-4, PPARγ agonists) and in vivo monocyte-derived M2 macrophages have recently been shown to express high levels of retinal dehydrogenase (ALDH1A2/RALDH), the rate-limiting enzyme for the production of retinoic acid, which, together with TGF-β, can promote the differentiation and expansion of a population of FoxP3 + Tregs known as iTregs (5)(6)(7)59). iTregs develop extrathymically in response to several soluble mediators, including TGF-β, IL-2, and retinoic acid, and in the gut, retinoic acid-mediated trafficking of T cells has been shown to be required for expansion of iTreg numbers (60).…”